Endogenous prostaglandins (PGs) influence resistance of the gastric mucosa to injury, but the source of PGs is unknown. Using radioimmunoassay, we studied PG production by dispersed canine fundic mucosal cells. PGE2 production, stimulated by bradykinin, epidermal growth factor, zymosan, and calcium ionophore, was greater in the small-cell elutriator fraction (SCEF) than in the medium and large cell fractions, which contained mucous, chief, and parietal cells. Linear density gradients of SCEF cells revealed maximal PGE2 production in cells of light density. Mast, endocrine, and endothelial cells did not account for this PGE2 production. Macrophages, identified by uptake of acetylated-LDL, immunoreactivity with antibodies to the human Ia antigen, and phagocytosis of fluorescent latex particles, were enriched in the SCEF and correlated with PGE2 production in the density gradient. Magnetic separation of cells in the SCEF-ingesting iron particles enriched PGE2 production. Fractions enriched in endothelial cells present in intact capillary fragments, but depleted of macrophages, also produced PGE2. Regulation of PGE2 production differed among cell types. Fibroblasts were easily cultured from submucosa, but were not detected in the SCEF. We conclude that macrophages and capillary endothelial cells are major producers of PGE2 in the canine fundic mucosa.
Introduction
Endogenous prostaglandins play an important role in modulating mucosal resistance to injury (1) . Inhibition of endogenous prostaglandin (PG) formation by nonsteroidal anti-inflammatory drugs induces upper gastrointestinal ulcers and their complications in humans (2) . Immunization of rabbits and dogs with PGE2 induces antibody formation and gastrointestinal ulcer formation. Despite the importance of endogenous PGs, there is little knowledge of the source of PGs in the gastric and duodenal mucosa. Therefore, it is difficult to study the regulation of PG production or assess the potential physiological or pathophysiological role of PGs in this complex tissue. Enzyme-dispersed canine fundic mucosal cells produce PGs at a rapid rate and, thus, provide a model for studying the cellular source of PG production. In the present study, we have separated cells by size and by density, and sought to determine the contribution to PGE2 production by specific cell types. Fundic mucosa bluntly separated from submucosa also con-step density-gradient techniques (6) . Gradient solutions were modified to control osmolality. The heavy solution (Hv) was 24% BSA (Boehringer Mannheim Biochemicals, Indianapolis, IN) plus 9% Ficoll (Pharmacia Fine Chemicals, Piscataway, NJ) dissolved in Hanks' balanced salt solution (HBSS, Irvine Scientific, Santa Ana, CA) that had been diluted to 47% of the normal salt concentration. The light solution (Lt) was 12% BSA dissolved in HBSS diluted to 88% ofthe normal salt concentration. Optimal results were obtained when solutions were allowed to dissolve by stirring overnight in a cold room. The solutions were pH adjusted to 7.4 with 1 N NaOH, brought up to volume, and then centrifuged at 3,000 rpm for 15 min to sediment debris. Solutions were either immediately used for density gradient or transferred to new 50-ml tubes and frozen at -70'C. Density and osmolality of the Hv and Lt solutions were checked routinely.
The linear-gradient separations were performed as described previously (5) . The Hv BSA solution (100 ml) was loaded into a zonal rotor (Sorvall-DuPont, Newtown, CT) to form a cushion and a linear gradient formed between the Hv and Lt BSA (600 ml each, density 1.085 and 1.030, respectively). Cells were loaded in 8% BSA and the gradient was centrifuged at 6,000 rpm for 30 min. Fractions (20 ml) were collected, diluted with HBSS to 50 ml, and centrifuged. After resuspension in HBSS, fractions were pooled in groups offour. Specific gravity of the fractions was measured before dilution.
PGE2 release assay. Cells were suspended (2 X 106 cells/ml) in HBSS with 2 mM glutamine, 15 mM Hepes, but without BSA. Cells were incubated at 37°C for 30 min in 20-ml glass scintillation vials in a rotary shaker bath (60 rpm) . After a baseline sample (to), test substances or vehicles were added and the medium was sampled again after 45 min (t45). Samples ofcell suspension were microfuged (8,700g) and the supernatant stored at -20°C for measurement of PGE2 concentration in the medium by RIA. Data are expressed as the increment in medium PGE2 concentration between to and t45, adjusted for cell count. In control studies (M. C. Chen, D. A. Amirian, and A. H. Soll, manuscript in preparation), the time course of PGE2 production was linear between 15 and 90 min, linearly dependent upon cell number [9] ). Both of these antibodies also may interact with Ia antigen present on lymphocytes and, therefore, three lymphocyte-specific markers were also utilized: DLy6 (Dr. H. J. Deeg [10] ) and lAl and 6C6 (Dr. D. R. Kraweic, Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign). Use of these antibodies is described in Table II . Uptake of dioctadecylindocarbocyanine (DiL)-labeled-acetylated-LDL (acLDL) (1 1, 12) (Table II) and lucifer yellow (13) (Coming Glass Works, Corning, NY) in 10 ml of Ham's F12:DME (1:1) (Irvine Scientific), supplemented with 10% calf serum (Irvine Scientific), 20 mM Hepes, 8 jug/ml insulin, and 50 Ag/ml gentamicin sulfate. After 2-3 d, the attached cells were removed from the T flasks by a trypsin-EDTA solution (Gibco Laboratories, Grand Island, NY) and passed to 75-cm2 T flasks at 1:3 dilution in fresh medium. These cells were then passed weekly for 2-3 mo. We have identified fibroblasts on the basis of their ability to be plated and maintained on untreated plastic culture substrates, their morphology in culture, and their ability to be subcultured by trypsinization.
DNA assay. We measured the DNA fluorometrically (19) using 4',6'-diamidine-2-phenylindole as the intercalator.
Statistical analysis. In all experiments, data were analyzed by Student's paired t test in which n refers to the number of separate cell preparations used, which equals the number of animals used.
Results
Stimulation of PGE2 production. The present studies are focused upon identification of the major PGE2-producing cells.
PGE2 production: cell separation by elutriation. Examining the elutriator fractions, basal PGE2 production was found to be greatest in the small cell fractions 2, 3, 4, and 5 ( Fig. 1 A) . PGE2 production, in response to bradykinin (1 ,uM) (Lys-bradykinin from Peninsula Laboratories, Inc., Belmont, CA) and A23187 (1 ,uM) (Calbiochem-Behring Corp., San Diego, CA), was also maximal in fractions 2, 3, and 4 ( Fig. 1 A) .2 Using this elutriator protocol, mucous, chief, and parietal cells are The distribution of various cell markers was examined as described in Methods and Table II , and data expressed as percentage of a given cell type. Macrophage markers were identified by immunohistochemistry with antibody to the human Ia antigen (7.2 Ab, *) and by the uptake of DiL labeled-acetylated-LDL (acLDL, *). Lymphocytes were examined with immunoreactivity against DLy-6 antibody (DLy-6, *). The capillary endothelial cells were identified by the presence of factor VIII-related antigen (F8 Ag, A). These data are from a single preparation, representative of four other similar studies.
enriched in fractions 4-5, 6-8, and 8-9, respectively (6), therefore indicating that these three mucosal cell types did not account for the major peak of PG production in the SCEF. There are several cell types present in the SCEF, including mast cells (5), endocrine cells containing somatostatin and glucagon (20) , and endocrine-like cells containing serotonin and DOPA-decarboxylase activity (20, 21) . Macrophage markers. Several potential macrophage markers were evaluated, including the uptake of acLDL (1 1 (Fig. 1 B) and B 1 F6-16 was present in both a rimmed and speckled pattern on cells in the SCEF; both patterns were considered positive (Figs. 2 B and 2 C). In our hands B IF6-16 detected more cells in the SCEF (18.3±4.1%, mean±SE, n = 9) than did antibody 7.2 (6.5±2.6%, mean±SE, n = 4).4 In colocalization studies 29±7% (mean±SE, n = 3) ofthe cells positive for B 1F6-16 also accumulated acLDL. All of the cells examined in these three cell preparations that had accumulated acLDL were immunoreactive with antibody B 1 F6-16. We also examined accumulation into cells of lucifer yellow (13) . This marker was positive in both large-and small-cell fractions (data not shown), indicating that this was not selective marker for a specific cell population in the canine fundus.
Phagocytosis of fluorescent latex particles was also assessed and 3.2±1.3% (mean±SE, n = 4) of the cells in the SCEF ingested latex particles, with an average of 6.6±2.1 (mean±SE, n = 4) latex particles per phagocytic cell (Fig. 2 D) . Of These markers were examined in the various elutriator fractions to further establish specificity. Immunoreactivity with antibody 7.2 and uptake of acLDL were consistently enriched in the SCEF and absent from the larger cell fractions 6-9 (Fig. 1 B; Table III ). The distribution pattern shifted slightly among preparations and macrophage markers were occasionally identified in fraction 5. The distribution of the Ta markers and the uptake of acLDL were present in fractions 2-4 of three complete elutriation profiles. Furthermore, cells phagocytic for latex particles were consistently detected in the small cell fractions 2-4, but were absent in larger cell fractions (n = 3, data not illustrated).
A panlymphocytic antibody (DLy-6), that detects both T and B cells, but not macrophages (10) , was positive on cells in elutriator fractions 3-5. The number of cells positive in the SCEF for this marker varied from 0 to 8.5% (n = 5). In the same preparations, the percentage of cells immunoreactive with DLy-6 (3.0±1.4%, meaniSE, n = 3) was considerably less than for the Ia antigen ( 12.1+5.0%, n = 3). A different pattern of distribution between 7.2 Ab and DLy-6 was found in the three elutriator gradients examined and cells accumulating acLDL were found to be negative for DLy-6 ( Fig. 1 B) .
from that found for macrophages in the SCEF. The Endothelial cell markers. Endothelial cells were identified using an antibody to factor VIII-related antigen (17, 18, 22) . On cryostat sections of whole mucosa, positive staining was only present over capillary structures in the lamina propria (data not illustrated). Using this antibody, intact capillary fragments were identified in the dispersed mucosal cell population (Fig. 3, left) . The FITC-lectin GS-1 also selectively bound to intact capillary fragments (Fig. 3, right) . In the SCEF a small number of single cells were positive for both factor VIII-related antigen (Fig. 1 B) and GS-1. Fragments of microvessel chains positive for these markers were present occasionally in the large cell elutriator fractions (fraction 9) and in the material remaining in the rotor at the end of the separation ("rest" fraction, Fig. 1 B) . Intact capillary fragments were enriched by selective filtration as described in Methods.
Sequential density gradient separation of the SCEF: PG production and cell markers. We performed a linear density gradient (Table IV) to further separate cells in the SCEF. In five separate density gradients, basal and bradykinin-stimulated PGE2 production were maximal in fractions of relatively light density (1.050-1.058 g/ml, Fig. 4 A) . The density of cells producing PGE2 production fell between those found for cells containing SLI and 5-HT-LI (n = 3, Fig. 4 B) . Mast cells (23) and a small number of endothelial cells were present in the dense portion of the gradient (n = 2, Fig. 4 C) , clearly distinct from fractions producing PGE2. However, antibody 7.2 to the Ia antigen was present in the same portion of the density gradient as was maximal PGE2 production, and correlated with PG production with a correlation coefficient (r) of 0.78 and 0.73 (n = 2 gradients; Fig. 4 D) .6 Cells positive for BlF6-16 also correlated with the distribution for bradykinin-enhanced PGE2 production (Fig. 4 E) (n = 2 gradients, r = 0.87 and 0.75). Cells taking up acLDL were also present in the same 6. The number of individual points examined in performing these correlation coefficients with PG production ranged between 10 and 12.
The P values for these correlation coefficients were all < 0.05. fractions as bradykinin-stimulated PGE2 production ( Fig. 4  D) ; the correlation coefficients in the two gradients examined were 0.85 and 0.92. Zymosan, a sulfated polysaccharide known to stimulate macrophage function (24), increased PGE2 production in the same density gradient fractions that responded to bradykinin (n = 2, Fig. 4 A) . In the two gradients studied, EGF also increased PGE2 production in the fractions that contained the macrophage markers (data not illustrated).
Phagocytosis oflatex particles. Phagocytosis of latex particles was found in cells of light density in the SCEF. These cells were recovered between 100% Lt layer and 40% Hv/60% Lt layer (a density of 1.053 g/ml) by step density gradient. In this cell fraction, 6.2±1.4% (n = 3) of the cells ingested latex particles, compared with < 1% of cells pelleting through the 40% Hv/60% Lt density step.
Iron separation ofputative macrophages. Iron particles covalently coupled to goat anti-mouse antibody (BioMag M4400) undergo phagocytosis. The BioMag apparatus separates cells that had taken up or bound these iron particles (attracted cells) from the remaining cells (nonattracted cells). PGE2 production was considerably greater in the attracted than in the nonattracted cells. The difference between attracted and nonattracted cells was greater when cells were incubated with iron particles at 37°C, compared with 4°C (Fig.  5) . This temperature effect suggests that phagocytosis of iron particles accounted for the enhanced PGE2 production in the attracted cell fraction. As a control for possible nonspecific effects of the iron particle separation on PGE2 production, SCEF cells were incubated with iron, exposed to a magnetic field, but resuspended without separating the attracted and nonattracted cells. These cells produced PGE2 at a rate indistinguishable from control SCEF cells (n = 3, data not shown). PGE2 production from fraction 6 or 7 cells incubated with iron particles was not significantly enhanced in the population attracted or trapped by magnetic field (Fig. 5) .
Iron separation was also done on SCEF cells following separation by step density gradient (Fig. 6 ). PGE2 production was considerably increased in the iron-attracted cells in the lightest density fraction, whereas iron-attracted cells in the intermediate and dense fractions produced little or no PGE2.
Glass adherence. Adherence to glass by the cells in the SCEF and by blood monocytes was evaluated. Canine blood monocytes readily adhered to glass and these adherent cells ingested latex particles; 3-TPA increased the number of phagocytotic cells (n = 3, data not illustrated). In contrast, only a small number of phagocytotic cells from the fundic SCEF adhered to glass under the same conditions. Endothelial cells. PGE2 production was enhanced in cell fraction remaining in the rotor at the end of a separation (the "rest" fraction, Fig. 1 B) . PGE2 production in this rest fraction was not related to the presence either of macrophages (none were found) (Table III) or of mucous, chief and parietal cells, which were present in greater enrichment in the medium and Figure 2 . Photomicrographs of macrophage markers. Cells in the SCEF were stained with various macrophage markers (see Table II Cytospins were made after washing (X500). larger cell fractions, respectively. Since intact capillary fragments were present in this rest fraction, we attempted to prepare fractions enriched in these capillary fragments using selective filtration over nylon mesh and elutriation. Microvessel fragments were retained on no. 195 nylon mesh. Although some enrichment was obtained with elutriation, recovery was low and separation from residual gastric gland fragments was poor. The fraction retained on the no. 195 filter was enriched to about 35±9% endothelial cells (n = 7) and provided an opportunity to evaluate the role of endothelial cells in PG production. This microvessel-enriched fraction did not contain cells with macrophage markers; specifically, cells did not react with antibody B 1 F6-16 (Table III , n = 4). Gastric gland fragments were the predominant contaminating cell type, and from our elutriator studies, the parietal, chief, and mucous cells that comprise these glands are not likely to be major PGE2 producers (Fig. 1 A) .
Comparison between PGE2 production by the SCEF, chief cells, and microvessels. We have compared PGE2 production by the SCEF, by an elutriator fraction enriched in chief cells, but containing mucous cells and parietal cells (fractions 5-7), and by the preparation enriched by filtration in intact capillary fragments. We have expressed PGE2 production data as picograms per microgram DNA (Fig. 7) . The SCEF had a basal PGE2 production rate that was four times that of fractions 5-7 and twice that of the microvessel fraction. Several agents differentially stimulated PGE2 production by these three populations. Bradykinin and the calcium ionophore A23187 stimulated PGE2 production in each fraction. In contrast, zymosan had a differential effect stimulating PGE2 by macrophagecontaining SCEF, but having no effect on endothelial cells, and only a minimal effect in fractions 5-7. Occasionally, a small number of cells with macrophage markers may be present in fraction 5, possibly accounting for the response to zymosan. Supporting this interpretation, in four recent experiments using only fractions 6 and 7, zymosan failed to stimulate PGE2 production (P > 0.2). Carbachol stimulated PGE2 production in both fractions 5-7 and in the endothelial cell fraction, but not in the SCEF. EGF stimulated PGE2 production in the SCEF and the endothelial cell fractions, but not in the chief cell-enriched fraction (Fig. 7) .
Fibroblasts. Since fibroblasts produce PGs (25), we sought to determine if fibroblasts were present in our elutriator fractions. For a positive control, we dispersed cells from the fundic submucosa; fibroblastic cells were easily cultured from elutriator fractions of these submucosal cells. During a 10-d culture period, T flasks that were sparsely seeded with submucosal cells became nearly confluent with fibroblastic cells. In contrast to the ease with which fibroblasts were obtained from these submucosal preparations, the same methods did not yield fibroblastic cultures from any of the elutriator-separated fundic mucosal fractions (2-4, 5-7, or 8-9; n = 4). Fig. 4 B. Experiment 2 is shown in Fig. 4 E. § 100 ml excess of light BSA solution was used in experiment 2 to form linear gradient to intentionally move the PG production peak to the center portion of the gradient. Discussion PGE2 production was rapid by dispersed canine fundic mucosal cells. Cell separation using the elutriator rotor indicated that the small cell fraction produced more PGE2 on a per cell basis than did the medium-or large-cell fractions. Since the latter fractions contained the mucous, chief, and parietal cells, it appears that nonepithelial cells are major contributors to PG production under these conditions. Enhanced PG production by the SCEF was found for basal PG production and PG production stimulated by the calcium ionophore A23 187, bradykinin, and epidermal growth factor. Since the calcium ionophore activates PG production by postreceptor mechanisms (26) , the distribution pattern we observed reflects not only the distribution of receptors, but also the capacity to produce PGs.
The PGE2 produced by this fraction reached 10 ng/ 106 cells per h and at this rate PGE2 concentrations in the medium would exceed 0.1 sM after a 1-h incubation, a concentration sufficient to modulate cell responses, such as inhibition of parietal cell function (27) .
The SCEF contained a variety of cell types and we utilized sequential density gradient to further discriminate cells. In these linear-density gradients, basal and bradykinin-stimulated PGE2 production occurred in a unimodal peak in fractions of relatively light density. No correlation was found between PGE2 production and markers for mast cells, endocrine and endocrine-like cells, or lymphocytes. However, close correlation was found with several macrophage markers: antibodies 7.2 and BlF6-16 to the Ta antigen and acLDL uptake.
Furthermore, zymosan, a sulfated polysaccharide that stimulates phagocytosis, also stimulated PGE2 production in the same fractions, supporting the conclusion that macrophages accounted for this distribution of PGE2 production.
The presence of macrophages in the SCEF was confirmed by several approaches. Cells ingested latex particles and accumulated acLDL and these cells were immunoreactive with the antibodies to the human Ia antigen. Cells in the SCEF exposed to iron particles and separated by magnetic field displayed markedly enhanced PG production; macrophages are well known to be separated by binding and/or phagocytosis of iron particles (16) . Furthermore, we separated the SCEF by step density gradient and found that iron separation enhanced PGE2 production only in the fraction of light density, the fraction enriched in macrophage markers. Furthermore, the chief cell-enriched fractions, which lacked macrophage markers, did not display any increase in PG production with iron separation. Taken together, these data indicate that macrophages account for the major proportion of PGE2 production in the small cell fraction. Macrophages and monocytes are known to produce PGE2 (28) (29) (30) (31) .
Identification of macrophages is complicated by species differences and macrophage heterogeneity. Species differences limit the utility of the immunological markers developed in rat, mouse or human for studies with canine macrophages. Most macrophage markers have been characterized on adherent blood monocytes or peritoneal or alveolar macrophages, and the characteristics of these cells may not be typical of macrophages in other tissues or microenvironments. The Ia antibodies that we utilized potentially interact both with macrophages and B lymphocytes (8, 9) . Our studies with a B lymphocyte specific marker make it unlikely that these lymphocytes accounted for the distribution of Ia marker we observed. Adherence to glass is frequently a useful property of macrophages that allows separation and identification. Although we found that canine monocytes readily adhered to glass, adherence was not useful in our studies with fundic macrophages. Whether this loss of adherence represents a characteristic of fundic macrophages or a consequence of the methodology we used remains unclear. Macrophages isolated from human intestine by Ficoll-Hypaque density gradient failed to adhere to glass or plastic (32) .
Macrophages may display heterogeneity, with discrete subpopulations responsible for functions such as phagocytosis, cytotoxicity, or PG production (30, 33, 34) . Exposure to specific signals or tissue environment may induce macrophages to differentially express a set of functions (35, 36) . Distinct heterogeneous subsets were clearly evident when peritoneal macrophages induced by Staphylococcus enteritidis were separated by sedimentation velocity; larger (high sedimentation velocity) macrophages were found to produce PGs, while smaller macrophages displayed enhanced cytolytic activity (33) . Since iron exposure and magnetic adherence enriches PG production in our studies, we conclude that phagocytic fundic macrophages produce PGE2. Whether the residual PGE2 production in the nonadherent population represents nonphagocytic macrophages or other cell populations remains uncertain.
Since macrophages possess the capacity to secrete factors amplifying tissue injury (e.g., lysosomal enzymes and superoxide) or factors potentially beneficial to mucosal defense (e.g., PGs) or mucosal repair and healing (fibroblast-stimulating factor), their number, state of activation, and expression of heterogenous functions may influence gastric mucosal sensitivity to injury and healing. Our data suggest that macrophages are an important cell to consider in assessing mucosal PG production. It is possible that the variable number and state of activation of macrophages underlie some of the variability of mucosal PG production among individuals.
Our present findings may have relevance to the capacity of the mucosa to enhance its resistance to injury following an initial minor insult, a phenomenon termed "adaptive cytoprotection" (37). As noted above, macrophages respond to inflammatory stimuli with enhanced release of prostaglandins (30, 31) . The increase in resistance to subsequent injury following treatment with mild injurious agents requires endogenous PG production (1, 37) . It is possible that macrophages are the cell responding to signals produced by mild tissue injury with an increased rate of PG production and, therefore, may participate in this adaptive response.
Endothelial cells also produce PGs (38) ; although prostacyclin (PGI2) is the major product of aortic endothelial cells, the type of PG and capacity for prostanoid production varies between major vessel and capillary endothelium (38, 39) . The relative quantitative importance of PG production by capillary endothelial cells in tissues remains uncertain. Utilizing antibodies to factor VIII-related antigen (17, 18, 22) Fibroblasts are another well recognized source of prostanoid production (25). We cultured fibroblasts from dispersed fundic submucosal cells, but not from any of the fundic elutriator fractions using similar conditions. These findings suggest that fibroblasts were, at most, present in small numbers in the dispersed canine fundic cell preparation and, therefore, were not major contributors to PG production in our small cell elutriator fraction.
The contribution of specific cell types in complex tissues to the overall rates of PG production remains uncertain. However, several lines of evidence obtained in studies with uterus, intestine, and kidney indicate that stromal or lamina propria elements, rather than epithelial cells, may be major PG producing cells (40) (41) (42) and that inflammatory cells specifically may be important contributors to tissue PG production. After the induction of hydronephrosis, renal PG production is markedly increased. This increase has been correlated with the migration of macrophages into the hydronephrotic kidneys; furthermore, the macrophage appear to induce fibroblast PG production (43, 44) . Additional evidence that inflammatory cells may be important PG producers comes from studies in heart tissue after ischemic injury (45). Among inflammatory cells, macrophages are very important PG producers. Polymorphonuclear cells produce leukotrienes, but appear to be only a minor source of prostanoid production (46) . Lymphocytes probably do not produce prostanoids in significant quantities (47) . We found a small, but variable, number of lymphocytes in our preparation, and lymphocyte markers did not correlate with the distribution of PGE2 production.
Previous studies have indicated that gastric mucosa pro-
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Chen et al. duces considerable quantities of PGs (48) (49) (50) . The different patterns of PG production found in these studies possibly reflect the different methodology and species employed. A few studies have been performed with dispersed or cultured mucosal cells. Both parietal cell enriched and depleted fractions generated prostaglandins (50) ; however, these studies did not identify other cell types, such as macrophages and endothelial cells. Contamination of the parietal cell fractions by these latter cell types requires consideration before these findings can be interpreted as reflecting parietal cell production. Cultured neonatal rabbit gastric cells were also found to produce PGs, but the rates of production were low and required addition of arachidonic acid to allow detection (5 1).
It is likely that all cells produce some prostanoids, but our present studies indicate that certain cell types may be major producers of prostanoids in the fundic mucosa. Our data do not exclude PG production by epithelial cells, but rather suggest that cells may vary considerably in their relative contribution to tissue PG production and that cells present in the lamina propria are important contributors to PG production. Our data indicate a correlation between stimulatable PGE2 and macrophage numbers present in SCEF. However, our data do not exclude the possibility that stimulatable PGE2 production may be the result of cell-cell interaction from macrophages and other epithelial cells.
We studied bradykinin stimulation of PG production in our isolated cell system because bradykinin is a well-described inducer of PG synthesis by fibroblasts (52), endothelial cells (53, 54) , and ileal lamina propria (55, 56) . We found that the distribution of bradykinin-stimulated PGE2 production both in density gradient and iron-separated fractions of SCEF corresponded to zymosan-stimulated PGE2 production and with macrophage markers. Canine fundic macrophages may thus account for a component of the bradykinin-stimulated PGE2 production in the small cell fraction. Bradykinin has not been reported as a stimulant of macrophage PG production (25, 57), although bradykinin does induce spreading of macrophages (58). It is possible that bradykinin only stimulates PG production in tissue macrophages under selected conditions. Bradykinin also stimulated PGE2 production in the endothelial cell-enriched fractions, but had no significant effect in the chief cell-enriched fraction.
EGF inhibits acid secretion and enhances gastric mucosal resistance to injury. EGF has also been reported to increase PG production by Madin-Darby canine kidney (MDCK) cells and by cultured mouse calvaria (59, 60) , however, direct effects of EGF on PG production in fundic mucosal cells have not been elucidated. In our studies, EGF increased PG production in the SCEF, presumably by a direct effect on macrophages, but data are insufficient to firmly establish this point. EGF also increased PG production by the endothelial cell enriched fraction, but not by the chief cell-enriched fraction. The relative importance of these EGF effects on PG production to the antisecretory and cytoprotective actions of EGF remains unclear. EGF inhibition ofisolated canine parietal cell function is not blocked by indomethacin treatment, suggesting that PG formation does not play a critical role at least in its antisecretory actions (M. C.-Y. Chen and A. H. Soll, unpublished observation). This result agrees with other studies by Konturek et al. (61) .
The cholinergic agonist carbachol stimulated PG production in the parietal and chief cell-enriched fraction, consistent with previous observations by others (62, 63) . Carbachol also increased PG production by the endothelial cell fraction, while stimulatory effects were not of statistical significance in the macrophage-containing SCEF. The differences were observed in the effects ofthese various stimuli on PG production among cell types probably reflects differences in distribution of receptors among these cell types. In contrast, the calcium ionophore A23 187 stimulated PG production in all of the cell fractions, although differences in the magnitude of response were observed.
We conclude that macrophages and endothelial cells are important prostanoid producers in the canine fundic mucosa. The factors that alter the number of these cells in the mucosa and that influence their rate of PG production may have a significant bearing upon mucosal resistance to injury. It is also possible that macrophages in gastric tissues under some circumstances exert deleterious effects by releasing mediators of injury, such as lysosomal enzymes and oxygen free radicals. Figure 7 . Comparison of PGE2 production by the SCEF, elutriator-enriched chief cell fraction and microvessel-enriched fraction. The SCEF (elutriator fractions 2-4) and the chief cell enriched elutriator fraction (5, 6, 7) were compared to the crude microvessel fraction collected by filtration. In three of these seven preparations, fractions 6 and 7 were collected instead of fractions 5 These cells may also play a key role in repair and healing, as they produce factors that induce fibroblast proliferation and collagen formation.
